↓ Skip to main content

Aripiprazole versus placebo for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, August 2011
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (74th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 tweeters
wikipedia
1 Wikipedia page

Citations

dimensions_citation
43 Dimensions

Readers on

mendeley
112 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Aripiprazole versus placebo for schizophrenia
Published in
Cochrane database of systematic reviews, August 2011
DOI 10.1002/14651858.cd006622.pub2
Pubmed ID
Authors

Ravindra B Belgamwar, Hany George G El-Sayeh

Abstract

First generation 'typical' antipsychotics such as chlorpromazine and haloperidol have been the mainstay of treatment up until the introduction of the second generation 'atypical' antipsychotics such as risperidone and olanzapine. Typical and atypical antipsychotics do provide a treatment response for most people with schizophrenia, whether a reduction in psychotic episodes or a lessening in the severity of their illness. However, a proportion of people still do not respond adequately to antipsychotic medication. Additionally, atypical and especially typical antipsychotics are associated with serious adverse effects, which can often compromise compliance with medication and therefore increase the incidences of relapse. In this review we examine the effects of aripiprazole compared with placebo.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 112 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 2 2%
United Kingdom 1 <1%
Unknown 109 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 25 22%
Student > Bachelor 19 17%
Researcher 15 13%
Student > Ph. D. Student 11 10%
Student > Doctoral Student 10 9%
Other 17 15%
Unknown 15 13%
Readers by discipline Count As %
Medicine and Dentistry 45 40%
Psychology 15 13%
Nursing and Health Professions 11 10%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Social Sciences 4 4%
Other 15 13%
Unknown 18 16%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 March 2016.
All research outputs
#3,707,908
of 14,083,287 outputs
Outputs from Cochrane database of systematic reviews
#6,552
of 10,839 outputs
Outputs of similar age
#40,963
of 164,423 outputs
Outputs of similar age from Cochrane database of systematic reviews
#54
of 112 outputs
Altmetric has tracked 14,083,287 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 10,839 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.6. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 164,423 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 112 others from the same source and published within six weeks on either side of this one. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.